Tiffany A. Karas, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 302 Randall Rd, Geneva, IL 60134 Phone: 630-208-6775 Fax: 630-208-7937 |
Elisa A Hofmann, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 302 Randall Rd, Geneva, IL 60134 Phone: 630-208-6775 Fax: 630-208-7937 |
Steven J. Bielski, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 302 Randall Rd, Geneva, IL 60134 Phone: 630-208-6775 Fax: 630-208-7937 |
Dr. Demetra Vlagos Rupp, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 302 Randall Rd, Geneva, IL 60134 Phone: 630-208-6775 Fax: 630-208-7937 |
News Archive
A two-day summit of the African Capacity Building Foundation (ACBF) in the Rwandan capital, Kigali, concluded on Wednesday with African leaders calling for stronger "efforts in building capacity that goes beyond achieving the Millennium Development Goals (MDGs) target of 2015," the New Times reports.
GHESKIO, an institution in Haiti founded nearly three decades ago to fight a mysterious killer disease later identified as AIDS, has been awarded the prestigious 2010 Gates Award for Global Health for its years of groundbreaking clinical service, research and training to effectively treat and prevent the spread of the HIV/AIDS and other related illnesses.
A University of Pennsylvania study will determine if public transit can convey more than people going from point A to point B. Video displays on public buses in Los Angeles will be used to help determine the efficacy of an innovative soap opera-like video program designed to increase HIV testing among low-income African Americans 14 to 24 years of age.
The FDA today approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women ages 10 years through 25 years.
› Verified 1 days ago